checkAd

     216  0 Kommentare Novus Therapeutics Announces Closing of $10.7 Million Registered Direct Offering Priced At-the-Market - Seite 3


    Business Wire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von Business Wire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Novus Therapeutics Announces Closing of $10.7 Million Registered Direct Offering Priced At-the-Market - Seite 3 Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced the closing of its previously announced …